MLAB - Mesa Laboratories, Inc.
NASDAQ
->
Technology
->
Scientific & Technical Instruments
Lakewood,
United States
Type: Equity
MLAB price evolution
MLAB
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $28.22 | $35.62 | $32.38 | $32.91 |
| Short term investments | ||||
| Net receivables | $36.02 | $36.34 | $35.59 | $42.55 |
| Inventory | $35.97 | $32.88 | $35.56 | $34.64 |
| Total current assets | $118.36 | $117.66 | $114.81 | $118.97 |
| Long term investments | ||||
| Property, plant & equipment | $31.77 | $28.57 | $27.95 | $28.15 |
| Goodwill & intangible assets | $578.96 | $480.95 | $489.15 | $503.26 |
| Total noncurrent assets | $623.41 | $519.53 | $527.8 | $542.86 |
| Total investments | ||||
| Total assets | $741.77 | $637.19 | $642.61 | $661.83 |
| Current liabilities | ||||
| Accounts payable | $4.55 | $4.81 | $5.59 | $6.13 |
| Deferred revenue | $14.36 | $14.32 | $15.37 | $14.41 |
| Short long term debt | ||||
| Total current liabilities | $44.18 | $39.82 | $39.13 | $43.36 |
| Long term debt | $232.97 | $170.73 | $175.5 | $183.27 |
| Total noncurrent liabilities | $294.63 | $209.61 | $215.77 | $224.99 |
| Total debt | $232.97 | $170.73 | $175.5 | $183.27 |
| Total liabilities | $338.81 | $249.43 | $254.89 | $268.35 |
| Shareholders' equity | ||||
| Retained earnings | $71.95 | $70.7 | $72.79 | $74.2 |
| Other shareholder equity | -$9.84 | -$20.81 | -$19.46 | $393.48 |
| Total shareholder equity | $402.96 | $387.76 | $387.72 | $393.48 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $32.91 | $49.35 | $263.87 | $81.38 |
| Short term investments | ||||
| Net receivables | $42.55 | $41.22 | $23.79 | $21.13 |
| Inventory | $34.64 | $24.61 | $11.18 | $14.23 |
| Total current assets | $118.97 | $124.32 | $303.75 | $122.79 |
| Long term investments | ||||
| Property, plant & equipment | $28.15 | $28.62 | $22 | $22.07 |
| Goodwill & intangible assets | $503.26 | $541.28 | $272.58 | $261.41 |
| Total noncurrent assets | $542.86 | $583.05 | $297.73 | $297.41 |
| Total investments | ||||
| Total assets | $661.83 | $707.37 | $601.48 | $420.21 |
| Current liabilities | ||||
| Accounts payable | $6.13 | $7.9 | $4.47 | $3.41 |
| Deferred revenue | $14.41 | $13.83 | $8.78 | $6.81 |
| Short long term debt | ||||
| Total current liabilities | $43.36 | $48.05 | $32.58 | $26.01 |
| Long term debt | $183.27 | $218.37 | $145.68 | $140.28 |
| Total noncurrent liabilities | $224.99 | $265.51 | $162.66 | $174.19 |
| Total debt | $183.27 | $218.37 | $145.68 | $140.28 |
| Total liabilities | $268.35 | $313.57 | $195.25 | $200.19 |
| Shareholders' equity | ||||
| Retained earnings | $74.2 | $76.67 | $72.46 | $71.93 |
| Other shareholder equity | -$12.79 | $3.67 | $16.12 | -$9.94 |
| Total shareholder equity | $393.48 | $393.8 | $406.23 | $220.01 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $53.47 | $53.16 | $50.65 | $55.59 |
| Cost of revenue | $20.07 | $21.06 | $19.46 | |
| Gross Profit | $33.4 | $32.11 | $31.18 | $33.2 |
| Operating activities | ||||
| Research & development | $4.29 | $4.99 | $4.81 | |
| Selling, general & administrative | $29.18 | $27.18 | $27.04 | |
| Total operating expenses | $29.6 | $32.53 | $31.07 | $32.68 |
| Operating income | $3.8 | -$0.42 | $0.11 | |
| Income from continuing operations | ||||
| EBIT | $3.8 | -$0.42 | $0.11 | |
| Income tax expense | -$0.17 | -$0.1 | -$0.39 | -$0.89 |
| Interest expense | $1.86 | $0.91 | $1.05 | |
| Net income | ||||
| Net income | $2.12 | -$1.23 | -$0.55 | $0.61 |
| Income (for common shares) | $2.12 | -$1.23 | -$0.55 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $219.08 | $184.34 | $133.94 | $117.69 |
| Cost of revenue | $85.39 | $75.25 | $46.92 | $52.75 |
| Gross Profit | $133.69 | $109.09 | $87.01 | $64.93 |
| Operating activities | ||||
| Research & development | $20.49 | $15.77 | $10.39 | $6.36 |
| Selling, general & administrative | $109.88 | $88.62 | $64.18 | $50.74 |
| Total operating expenses | $130.37 | $104.39 | $74.66 | $56.96 |
| Operating income | $3.32 | $4.7 | $12.36 | $7.98 |
| Income from continuing operations | ||||
| EBIT | $4.38 | $7.46 | $10.33 | $8.94 |
| Income tax expense | -$1.32 | $1.7 | -$0.97 | $2.08 |
| Interest expense | $4.77 | $3.88 | $8.02 | $5.5 |
| Net income | ||||
| Net income | $0.93 | $1.87 | $3.27 | $1.35 |
| Income (for common shares) | $0.93 | $1.87 | $3.27 | $1.35 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $2.12 | -$1.23 | -$0.55 | $0.61 |
| Operating activities | ||||
| Depreciation | $9.05 | $8.1 | $8.13 | $9.05 |
| Business acquisitions & disposals | -$79.7 | |||
| Stock-based compensation | $2.99 | $3.18 | $2.97 | $2.68 |
| Total cash flows from operations | $11.54 | $9.78 | $9.94 | $12.52 |
| Investing activities | ||||
| Capital expenditures | -$1.13 | -$0.63 | -$0.27 | -$1.03 |
| Investments | ||||
| Total cash flows from investing | -$80.83 | -$0.63 | -$0.27 | -$1.03 |
| Financing activities | ||||
| Dividends paid | -$0.86 | -$0.86 | -$0.86 | -$0.86 |
| Sale and purchase of stock | $0 | $0.3 | $0.05 | $2.47 |
| Net borrowings | $62 | -$5 | -$8 | -$6 |
| Total cash flows from financing | $60.85 | -$5.56 | -$9.52 | -$4.39 |
| Effect of exchange rate | $1.05 | -$0.34 | -$0.68 | -$0.29 |
| Change in cash and equivalents | -$7.39 | $3.24 | -$0.53 | $6.81 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $0.93 | $1.87 | $3.27 | $1.35 |
| Operating activities | ||||
| Depreciation | $33.82 | $25.07 | $17.66 | $12.99 |
| Business acquisitions & disposals | -$4.95 | -$300.79 | -$184.1 | |
| Stock-based compensation | $12.54 | $11.39 | $9.27 | $5.53 |
| Total cash flows from operations | $27.98 | $39.22 | $37.07 | $26.56 |
| Investing activities | ||||
| Capital expenditures | -$4.54 | -$4.43 | -$1.99 | -$1.48 |
| Investments | ||||
| Total cash flows from investing | -$9.49 | -$305.23 | -$1.99 | -$185.59 |
| Financing activities | ||||
| Dividends paid | -$3.41 | -$3.34 | -$3.17 | -$2.72 |
| Sale and purchase of stock | $7 | $7.15 | $150.36 | $89.94 |
| Net borrowings | -$36 | $49 | -$0.66 | $144.07 |
| Total cash flows from financing | -$33.33 | $52.58 | $146.23 | $231.28 |
| Effect of exchange rate | -$1.6 | -$1.09 | $1.18 | -$1.06 |
| Change in cash and equivalents | -$16.44 | -$214.52 | $182.49 | $71.19 |
News
Fundamentals
| Market cap | $543.40M |
|---|---|
| Enterprise value | $748.14M |
| Shares outstanding | 5.39M |
| Revenue | $212.87M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $948.00K |
| Revenue Q/Q | -1.50% |
| Revenue Y/Y | N/A |
| P/E ratio | 573.20 |
|---|---|
| EV/Sales | 3.51 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.55 |
| P/B ratio | 1.32 |
| Book/Share | 76.53 |
| Cash/Share | 5.23 |
| EPS | $0.18 |
|---|---|
| ROA | 0.14% |
| ROE | 0.24% |
| Debt/Equity | 0.68 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.68 |
| Quick ratio | 1.86 |